Lipin Kao (Betty), a certified project manager, received her Ph.D. in Biomedical Engineering from Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Australia and postdoctoral studies in Cancer Biology. Her thesis focused on the mitochondrial role in human embryonic stem cells. She has extensive publications in reputed journals, covered genetic expression profile, cell biology (stem cells, and cancer cells), mitochondrial biology, cancer biology, neuroscience, toxicology, and pharmacology, and has been serving as an reviewer and an editorial board member of repute.
Dr. Shafikhani is an Associate Professor in the Department of Medicine, Division of Hematology, Oncology, and Cell therapy at Rush University Medical Center. Dr. Shafikhaniâ€™s group is interested in understanding how the presence of tumor and infection lead to a state of immune-confusion affecting both anti-tumor and anti-bacterial immune defenses. His group is also interested in developing bacterial toxins as effective anti-cancer therapeutics. His group is also interested in innate immune dysregulation that renders diabetic wounds vulnerable to infection.
Prof. Dr. Kadriye Benkli has completed her PhD from Health Science Institute in
Anadolu University, Eskisehir, Turkey and postdoctoral studies from Leiden University,
Gorleous Lab., Leiden, The Netherlands. Her research interests include regulation of
cancer. Currently, she is a Head of Pharmaceutical Chemistry Department, Faculty of
Pharmacy, Girne American University.